01.003 RWE CW APR 2022 B (A) 18-04-2022

Cancer research benefits from utilising real world data (RWD)

  • “COTA is committed to creating a precise, patient-first approach to cancer care through the use of real-world evidence.”
  • “Another critical issue that real-world data is beginning to help solve is the lack of diversity in clinical trials…We use real-world data to explore differences in tumour biology. Treatment patterns, and outcomes to further characterise disparities in underrepresented and underserved populations.”
  • “Offering the highest quality oncology real-world data from leading academic and community-based cancer centers ensures that everyone touched by cancer has a clear path to the right care.”

Viraj Narayanan

Vice President of Life Sciences COTA inc.

Click here to learn more.

About SVMPharma

SVMPharma is an innovative strategic consultancy and CRO, with a focus in Real World Evidence (RWE) for pharmaceutical and biotechnology companies. SVMPharma delivers clinical trials within UK and Europe.


DISTILL is a new EDC launched by SVMPharma. As a CRO discover the benefits of DISTILL as part of your service offering and take back control of your clinical trials. DISTILL allows you to develop and manage every aspect of your trials from start to finish. Move away from the restrictions and costs associated with legacy systems.

For more information, please visit and contact us at